A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy
暂无分享,去创建一个
[1] E. Keeffe,et al. Re‐treatment of chronic hepatitis C with consensus interferon , 1998, Hepatology.
[2] J. Lau,et al. Virology of hepatitis C virus. , 1997, Clinics in liver disease.
[3] G. Davis,et al. Treatment of acute and chronic hepatitis C. , 1997, Clinics in liver disease.
[4] A. Sanyal,et al. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C , 1997, Hepatology.
[5] C. Schroeder,et al. Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein. , 1997, The Journal of general virology.
[6] H. Thomas,et al. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. , 1996, Journal of hepatology.
[7] T. Poynard,et al. Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration , 1996, Hepatology.
[8] S. Zeuzem,et al. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays , 1996, Journal of clinical microbiology.
[9] O. Weiland,et al. Combined treatment with interferon alpha‐2b and ribavirin for chronic hepatitis C in patients with a previous non‐response or non‐sustained response to interferon alone , 1995, Journal of medical virology.
[10] M. Nahata,et al. Rimantadine: A Clinical Perspective , 1995, The Annals of pharmacotherapy.
[11] L. Stuyver,et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. , 1993, The Journal of general virology.
[12] K. Martin,et al. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import , 1991, Cell.
[13] R. Belshe,et al. Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver disease , 1987, Clinical pharmacology and therapeutics.
[14] Y. Ghendon,et al. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine , 1980, Journal of virology.
[15] O. Weiland,et al. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. , 1998, Lancet.